Adam Mizeracki

2.6k total citations · 1 hit paper
12 papers, 1.8k citations indexed

About

Adam Mizeracki is a scholar working on Surgery, Oncology and Molecular Biology. According to data from OpenAlex, Adam Mizeracki has authored 12 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 6 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Adam Mizeracki's work include Vascular Tumors and Angiosarcomas (5 papers), Vascular Malformations and Hemangiomas (5 papers) and Cardiac Arrest and Resuscitation (2 papers). Adam Mizeracki is often cited by papers focused on Vascular Tumors and Angiosarcomas (5 papers), Vascular Malformations and Hemangiomas (5 papers) and Cardiac Arrest and Resuscitation (2 papers). Adam Mizeracki collaborates with scholars based in United States, Sweden and Switzerland. Adam Mizeracki's co-authors include Paula E. North, Milton Waner, Martín C. Mihm, Robert E. Mrak, Robin A.J. Nicholas, Jay Kincannon, J. Y. Suen, Charles A. James, Ilona J. Frieden and Na Li and has published in prestigious journals such as Molecular and Cellular Biology, Biochemical and Biophysical Research Communications and Journal of the American Academy of Dermatology.

In The Last Decade

Adam Mizeracki

12 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

GLUT1: A newly discovered immunohistochemical marker for juvenile hemangiomas

2000 557 citations Paula E. North, Milton Waner et al. Human Pathology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Adam Mizeracki United States	11	1.1k	635	568	451	389	12	1.8k
Tinte Itinteang New Zealand	27	965 0.8×	749 1.2×	1.1k 2.0×	545 1.2×	309 0.8×	88	2.5k
Adrienne M. Hammill United States	19	1.1k 1.0×	422 0.7×	198 0.3×	406 0.9×	389 1.0×	62	1.6k
Victor Kokta Canada	20	387 0.3×	440 0.7×	242 0.4×	168 0.4×	213 0.5×	42	1.2k
Kalliopi Stefanaki Greece	25	511 0.4×	553 0.9×	633 1.1×	209 0.5×	309 0.8×	129	2.3k
Helen D. Brasch New Zealand	22	504 0.4×	389 0.6×	591 1.0×	285 0.6×	139 0.4×	66	1.3k
Kyle C. Kurek United States	17	549 0.5×	296 0.5×	594 1.0×	235 0.5×	174 0.4×	46	1.4k
Joseph G. Pressey United States	23	209 0.2×	512 0.8×	550 1.0×	189 0.4×	260 0.7×	72	1.5k
Taina A. Partanen Finland	19	544 0.5×	1.3k 2.0×	1.1k 2.0×	162 0.4×	95 0.2×	24	2.1k
Richard Chang United States	26	860 0.8×	884 1.4×	433 0.8×	421 0.9×	110 0.3×	48	2.4k
Jeremy A. Goss United States	15	560 0.5×	374 0.6×	114 0.2×	314 0.7×	125 0.3×	33	956

Countries citing papers authored by Adam Mizeracki

Since Specialization

Citations

This map shows the geographic impact of Adam Mizeracki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Mizeracki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Mizeracki more than expected).

Fields of papers citing papers by Adam Mizeracki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam Mizeracki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Mizeracki. The network helps show where Adam Mizeracki may publish in the future.

Co-authorship network of co-authors of Adam Mizeracki

This figure shows the co-authorship network connecting the top 25 collaborators of Adam Mizeracki. A scholar is included among the top collaborators of Adam Mizeracki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Mizeracki. Adam Mizeracki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Rossini, Lorenzo, Oscar Ö. Braun, Michela Brambatti, et al.. (2020). Intraventricular Flow Patterns in Patients Treated with Left Ventricular Assist Devices. ASAIO Journal. 67(1). 74–83. 14 indexed citations

2.

Brown, Michael C., et al.. (2016). Mineralocorticoid Receptor Antagonists in the Management of Heart Failure and Resistant Hypertension. JAMA Cardiology. 1(5). 607–607. 14 indexed citations

3.

Khouzam, Rami N., et al.. (2014). Next-Generation Airbags and the Possibility of Negative Outcomes Due to Thoracic Injury. Canadian Journal of Cardiology. 30(4). 396–404. 7 indexed citations

4.

Ding, Zufeng, Adam Mizeracki, Chang-Ping Hu, & Jawahar L. Mehta. (2013). LOX-1 deletion and macrophage trafficking in atherosclerosis. Biochemical and Biophysical Research Communications. 440(2). 210–214. 23 indexed citations

5.

Singla, Sandeep, Chang‐Ping Hu, Adam Mizeracki, & Jawahar L. Mehta. (2011). Decorin in atherosclerosis. Therapeutic Advances in Cardiovascular Disease. 5(6). 305–314. 14 indexed citations

6.

Zhang, Yu, Teppei Yamaguchi, Fabien Cubizolles, et al.. (2008). Mice Lacking Histone Deacetylase 6 Have Hyperacetylated Tubulin but Are Viable and Develop Normally. Molecular and Cellular Biology. 28(5). 1688–1701. 453 indexed citations

7.

Sánchez‐Carpintero, I., Martín C. Mihm, Adam Mizeracki, Milton Waner, & Paula E. North. (2004). Epithelial and mesenchymal hamartomatous changes in a mature port-wine stain: morphologic evidence for a multiple germ layer field defect. Journal of the American Academy of Dermatology. 50(4). 608–612. 39 indexed citations

8.

North, Paula E., Adam Mizeracki, M. C. Mihm, & Robert E. Mrak. (2003). GLUT1 immunoreaction patterns reliably distinguish hemangioblastoma from metastatic renal cell carcinoma.. PubMed. 19(3). 131–7. 20 indexed citations

9.

North, Paula E., Milton Waner, Adam Mizeracki, et al.. (2001). Somatic mutation of vascular endothelial growth factor receptors in juvenile hemangioma. Genes Chromosomes and Cancer. 33(3). 295–303. 145 indexed citations

10.

North, Paula E., Milton Waner, Charles A. James, et al.. (2001). Congenital Nonprogressive Hemangioma. Archives of Dermatology. 137(12). 1607–20. 206 indexed citations

11.

North, Paula E., Milton Waner, Adam Mizeracki, et al.. (2001). A unique microvascular phenotype shared by juvenile hemangiomas and human placenta.. PubMed. 137(5). 559–70. 311 indexed citations

12.

North, Paula E., Milton Waner, Adam Mizeracki, & Martín C. Mihm. (2000). GLUT1: A newly discovered immunohistochemical marker for juvenile hemangiomas. Human Pathology. 31(1). 11–22. 557 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact